Wockhardt Shares Soar Over 11% After USFDA Approval: What Indian Investors Need to Know
Wockhardt Ltd. shares jumped over 11% after receiving USFDA approval for its novel antibiotic, Zaynich. Here’s what this means for Indian investors and the pharma industry.